Human brain networks mediating interoceptive, behavioral, and cognitive aspects of glycemic control are not well studied. Using group independent component analysis with dual-regression approach of functional magnetic resonance imaging data, we examined the functional connectivity changes of large-scale resting state networks during sequential euglycemic-hypoglycemic clamp studies in patients with type 1 diabetes and nondiabetic controls and how these changes during hypoglycemia were related to symptoms of hypoglycemia awareness and to concurrent glycosylated hemoglobin (HbA1c) levels. During hypoglycemia, diabetic patients showed increased functional connectivity of the right anterior insula and the prefrontal cortex within the executive control network, which was associated with higher HbA1c. Controls showed decreased functional connectivity of the right anterior insula with the cerebellum/basal ganglia network and of temporal regions within the temporal pole network and increased functional connectivity in the default mode and sensorimotor networks. Functional connectivity reductions in the right basal ganglia were correlated with increases of self-reported hypoglycemic symptoms in controls but not in patients. Resting state networks that showed different group functional connectivity during hypoglycemia may be most sensitive to glycemic environment, and their connectivity patterns may have adapted to repeated glycemic excursions present in type 1 diabetes. Our results suggest that basal ganglia and insula mediation of interoceptive awareness during hypoglycemia is altered in type 1 diabetes. These changes could be neuroplastic adaptations to frequent hypoglycemic experiences. Functional connectivity changes in the insula and prefrontal cognitive networks could also reflect an adaptation to changes in brain metabolic pathways associated with chronic hyperglycemia.
Introduction
The successful homeostatic control of blood glucose levels requires interoceptive sensing of declining glycemic levels, as well as a complex behavioral response involving awareness of hypoglycemic symptoms, motivation, and nutrient intake. Brain functional units organized as interconnected networks mediate these neural processes. The insula integrates interoceptive, exteroceptive, and emotional awareness with cognitive control (Simmons et al., 2013) . The basal ganglia are involved in learning, motivated behaviors, and habit formation (Yin and Knowlton, 2006) . The
Significance Statement
The major factor limiting improved glucose control in type 1 diabetes is the significant increase in hypoglycemia associated with insulin treatment. Repeated exposure to hypoglycemia alters patients' ability to recognize the autonomic and neuroglycopenic symptoms associated with low plasma glucose levels. We examined brain resting state networks during the induction of hypoglycemia in diabetic and control subjects and found differences in networks involved in sensorimotor function, cognition, and interoceptive awareness that were related to chronic levels of glycemic control. These findings identify brain regions that are sensitive to variations in plasma glucose levels and may also provide a basis for understanding the mechanisms underlying the increased incidence of cognitive impairment and affective disorders seen in patients with diabetes.
prefrontal cortex is critical for cognition and executive control. However, little is known about the coordinated functioning of these brain regions as networks to mediate the cognitive and behavioral aspects related to changes in blood glucose levels.
In this study, we investigated large-scale brain resting state network (RSN) functional connectivity (FC) changes during the gradual induction of hypoglycemia in patients with type 1 diabetes mellitus (T1DM) using blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI). We analyzed whole-brain fMRI time series using independent component analysis (ICA) to detect RSNs Fox and Raichle, 2007) . A better understanding of how FC changes during hypoglycemia in T1DM and of the differences between patients with T1DM and healthy subjects may help identify therapeutic targets for reducing the effect of hypoglycemia on the brain.
T1DM is caused by autoimmune destruction of pancreatic ␤ cells, resulting in nearly complete deficiency of insulin secretion. Patients must take exogenous insulin by subcutaneous injection, typically two to four separate injections per day or by a continuous infusion pump, to maintain control of plasma glucose levels. Because of the inevitable mismatches that occur between the administered insulin dose and daily variations in food intake and physical activity, periods of excessive hyperglycemia or hypoglycemia occur frequently. Because the brain relies almost exclusively on plasma glucose as an energy source, the effect of hypoglycemia on brain function is an area of intense physiological and clinical interest. Our goal was to study the response to a gradual glucose decline experienced typically by an individual with T1DM during daily life. Glucose also provides precursors to excitatory glutamate and inhibitory GABA neurotransmitters, shown to predict large-scale network connectivity (Kapogiannis et al., 2013) . We showed previously that increased hemoglobin A1c (HbA1c) is associated with increased brain glucose and glutamate-glutamine-GABA, with decreased memory and executive function and increased depressive symptom scores, suggesting that perturbed neurotransmitter metabolism related to persistent hyperglycemia may affect brain function (Lyoo et al., 2009 ). Thus, glycemic excursions could affect basal neurotransmitter metabolism and brain network connectivity and function. Plasma insulin may also alter regional brain glucose metabolism (Schulingkamp et al., 2000; Bingham et al., 2002) and affect brain function (Craft and Watson, 2004) . By using the hyperinsulinemic clamp method to induce euglycemia and hypoglycemia while maintaining plasma insulin at the same level in both groups during fMRI, we investigated glucose effects independently of insulin effects.
Based on our findings of altered task activation in a working memory-related network during hypoglycemia (Bolo et al., 2011) , we hypothesized that FC changes during hypoglycemia in cognitive RSNs of patients with T1DM would differ from those of nondiabetic controls. We further hypothesized that connectivity changes within RSNs would be associated with changes in participant's perception of hypoglycemia-related neuroglycopenic and autonomic symptoms.
Materials and Methods
Subjects. The study sample consisted of 16 patients with T1DM (six females and 10 males) and 10 age-matched healthy nondiabetic controls (two females and eight males). Some data from 10 patients with T1DM and seven controls were included in previous publications (Musen et al., 2008; Bolo et al., 2011) . Demographic and clinical characteristics of the subjects are presented in Table 1 .
Patients with T1DM had a clinical history of sudden onset of significant hyperglycemia in a previously healthy young individual and were dependent on insulin to control hyperglycemia from the time of their initial presentation. All were currently treated with multiple daily insulin injections or a continuous subcutaneous insulin infusion pump. Diabetic and control subjects were excluded if they had the following: (1) clinically significant cardiovascular, neurologic, or psychiatric disease or malignancy; (2) drug or alcohol abuse; or (3) any contraindications to MRI, such as metallic implants, pregnancy, or claustrophobia. Diabetic subjects were also excluded if they had clinical evidence of autonomic or peripheral neuropathy, diabetic nephropathy, albumin excretion rates Ͼ 300 mg/d, or evidence of proliferative retinopathy by physical exam, review of medical records, or self-report. Subjects on any antihypertensive medication or with a history of hypertension were also excluded. Only right-handed subjects were included in the study.
The study protocol was approved by the Institutional Review Boards at Joslin Diabetes Center, where subjects were recruited and screened, and McLean Hospital, where the MRI studies were performed. All subjects gave informed voluntary written consent before participating.
Experimental protocol. The experimental protocol has been described previously (Musen et al., 2008; Bolo et al., 2011) and briefly reviewed below. All studies were performed in the morning after an overnight fast. Patients with T1DM had a continuous glucose monitor (CGM System Gold; Medtronic) inserted on the day before the study. If the continuous glucose monitor showed glucose Ͻ 3.3 mmol/L, the study was postponed to a later date. Patients were instructed that the goal was to achieve a fasting glucose of 5.0 -6.7 mmol/L on the morning of the study. The study diabetologist (D.C.S.) was in contact with the patients throughout this time to answer questions and assist with insulin dose managements. The experiment used the insulin clamp technique with four successive time periods corresponding to different plasma glucose levels: (1) baseline (30 min); (2) euglycemic clamp (40 min, target glucose of 5.0 mmol/ L); (3) declining glycemia (40 min, plasma glucose reduced from 5.0 to 16 Ϯ 6 ͓5-27͔ -Fasting insulin (U/ml) 7.6 Ϯ 6.2 ͓1.0-17.9͔ 7.9 Ϯ 6.1 ͓1.9-17.2͔ Body mass index (kg/m 2 ) 24 Ϯ 3 ͓21-31͔ 24 Ϯ 2 ͓21-27͔ Systolic blood pressure (mmHg) 123
Data are presented as mean Ϯ SD ͓range͔; n is number of subjects in group. Group comparisons: *p Ͻ 0.05, ***p Ͻ 0.001.
2.8 mmol/L); and (4) hypoglycemic clamp (30 min, target glucose of 2.8 mmol/L). The MRI scanning began between 9:00 A.M. and 9:30 A.M. for all subjects. Anatomical MRI was performed during baseline, and fMRI was performed continuously during the last 5 min of the euglycemic period and the 40 min of the declining glucose period (total of 45 min; Fig. 1 ). Insulin clamp technique. An intravenous catheter was inserted into an antecubital vein for the administration of insulin and glucose, and a second catheter was inserted into a distal forearm or hand vein for the withdrawal of blood samples. A heated gel pack was used to warm the hand to arterialize the venous blood. After the baseline period, regular human insulin was infused at 12 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 (2 mU ⅐ kg Ϫ1 ⅐ min Ϫ1 ) for 110 min (Fig. 1) . Plasma glucose was maintained at the desired level by infusion of 20% dextrose using a negative-feedback algorithm. After the euglycemic clamp period (40 min), the glucose infusion rate was reduced to allow the plasma glucose level to decline by 2.2 mmol/L (from 5.0 to 2.8 mmol/L) over the next 40 min, followed by the 30 min hypoglycemic clamp period (Fig. 1) . During the entire clamp protocol, glucose levels were measured every 5 min, and counterregulatory hormones (epinephrine, cortisol, growth hormone, and glucagon) were measured every 10 min. At the end of the protocol, the insulin infusion was discontinued, euglycemia was restored, and the subjects were given a meal.
Analytical methods. Plasma glucose was measured by the glucose oxidase method. Cortisol and glucagon were measured by radioimmunoassay. Epinephrine, growth hormone, and insulin were measured by ELISA. Statistical comparisons between groups were made using paired or unpaired Student's t test, as appropriate, and ANOVA with repeated measures over time. Counter-regulatory hormones were analyzed using a longitudinal linear mixed-effects model adjusting for baseline. Prespecified contrasts between groups at each time point were performed.
Assessment of symptoms associated with hypoglycemia. On the day of the study, we administered a questionnaire (Clarke et al., 1995) to assess subjective and objective measures of hypoglycemia awareness. Patients were asked to answer questions related to the presence or absence of hypoglycemia, the blood glucose level at which symptoms occur, and the ability to sense symptoms. All subjects also responded to a hypoglycemic symptom questionnaire just before the 45 min fMRI run (during the euglycemic clamp) and just after the end of the fMRI run (during the hypoglycemic clamp; Fig. 1 ). The hypoglycemia symptom questionnaire comprised nine symptoms: four that were predominantly autonomic (trembling, sweating, pounding heart, fast pulse) and five that were predominantly neuroglycopenic (lightheaded, difficulty concentrating, feeling uncoordinated, feeling confused, feeling weak). Symptoms were presented on a backlit screen, visualized from within the magnet bore by a mirror mounted on the head coil, using Presentation software (Neurobehavioral Systems). Responses were made by moving a cursor on the screen to the number that corresponded to the intensity of each symptom using a magnetic resonance-compatible hand-held four-button fiberoptic response pad (fORP; Current Designs). Subjects were asked to rate each symptom on a Likert scale from one (feeling the symptom "not at all") to seven (feeling the symptom "a lot"). The autonomic and neuroglycopenic symptom scores, respectively, were determined as the sums of the scores for the individual symptoms.
MRI and fMRI data acquisition. Acquisition of MRI and fMRI data was performed using a 3.0 tesla Trio whole body scanner (Siemens), with a circularly polarized birdcage radio frequency head coil tuned to the proton frequency. Global field uniformity was adjusted at the beginning of each scanning session using Siemens automated shimming routines. A three-dimensional (3D) T1-weighted anatomical image was acquired using a magnetization-prepared rapid-acquisition gradient-echo sequence (TR, 2100 ms; TE, 2.74 ms; spatial resolution, 1 ϫ 1 ϫ 1.3 mm 3 ; matrix size, 256 ϫ 256 ϫ 128) and used for functional image registration. BOLD fMRI images covering the whole brain were acquired in the coronal plane using an echo planar imaging sequence ( matrix size, 64 ϫ 64) with an in-plane resolution of 3.1 ϫ 3.1 mm 2 . A total of 450 EPI multislice volumes were acquired to cover the 45 min period composed of an initial 5 min of euglycemia, followed by 40 min of declining glycemia (Fig. 1) . One multislice volume covering the whole brain was acquired every 6 s. Our relatively long TR of 6 s is not ideal but was a tradeoff in balancing other study-related issues. We were interested in detecting the low-frequency spontaneous oscillations in BOLD signals (ϳ0.01-0.08 Hz, i.e., one cycle approximately every 12-100 s), for which long TR has less impact compared with detecting more rapid task activation-related BOLD changes. We mitigated as much as possible the effects of long TR by using the full 45 min time course in the group ICA to include as many oscillations as possible and by using 10 min of fMRI data to compare the euglycemic and hypoglycemic conditions (see below, Dual regression procedure).
fMRI data preprocessing. All fMRI time series were preprocessed using FMRIB (for Functional MRI of the Brain) FEAT (fMRI Expert Analysis Tool) version 5.98, part of the FMRIB Software Library (FSL; www. fmrib.ox.ac.uk/fsl; and included the following: (1) head motion correction using FLIRT (FMRIB Linear Registration Tool; Jenkinson et al., 2002) ; (2) non-brain removal using FSL BET (Brain Extraction Tool; Smith, 2002); (3) spatial smoothing by a Gaussian kernel (full-width at half-height, 5 mm); (4) grandmean intensity normalization of the entire 4D dataset by a single multiplicative factor; and (5) high-pass temporal filtering by subtraction of a Gaussian-weighted least-squares straight line fitting with ϭ 50 s. Subjects' fMRI data were first registered to their high-resolution structural image using FLIRT , which were then registered to MNI-152 standard space using FLIRT, followed by FNIRT (FMRIB Nonlinear Image Registration Tool; Jenkinson et al., 2012) . All subjects' time series data were transformed into standard space at 2 ϫ 2 ϫ 2 mm resolution using the registration transformation matrices before the group ICA.
Group ICA. The entire fMRI time series for all subjects were concatenated in the temporal dimension and a group temporal concatenate probabilistic ICA (PICA; Beckmann et al., 2005) was implemented using FSL MELODIC (Multivariate Exploratory Linear Decomposition into Independent Components) version 3.09. The PICA estimates a set of spatiotemporal patterns that comprise the BOLD fMRI time series corresponding to underlying RSNs and artifactual processes that give rise to correlated BOLD signals. We set the number of components to 30 to obtain component spatial patterns consistent with the literature for the most frequently reported major large-scale RSNs [e.g., default mode network (DMN)]. To ensure stable convergence of the ICA, it was run eight times and followed by a meta-level ICA using spatial maps from the eight decompositions ) to identify the set of independent components (ICs), including RSNs and ICs related to artifacts, common to all participants. Through comparison of brain networks reported previously Kullmann et al., 2012) and cross-correlation with template networks available at http://www.fmrib. ox.ac.uk/analysis/brainmap ϩrsns/ and the reference by , the resulting ICs were inspected visually to identify RSNs involved in sensorimotor, cognitive, and limbic functions , interoception, RSNs investigated previously in a study of obesity by Kullmann et al. (2012) , and an RSN containing the hypothalamus. This resulted in a total of seven components that were subjected to additional statistical analyses.
Dual regression procedure. To assess condition and group differences in RSN FC, we used the dual regression approach , which has been shown to be a robust optimal approach for assessing intersubject variability with group ICA of fMRI data (Allen et al., 2012) . This approach is informative of the specific shape of the RSN (i.e., localization and extent of all regions that constitute each RSN in a given subject or group of subjects), the degree of correlation among the time courses of the regions in the RSN (i.e., correlation coefficient), and the between network FC of large-scale RSNs, all together constituting a full picture of RSN behavior, which permits the assessment of group and condition differences.
To investigate differences in FC between the two conditions of euglycemia (EU) and hypoglycemia (HY), we defined condition-specific time courses by extracting, respectively, the first and last 10 min of the full 45 min time course during which blood glucose levels gradually declined. During the first 5 min of the full fMRI time course, blood glucose levels were clamped at euglycemic levels, after which glucose infusion was decreased to initiate onset hypoglycemia at a rate of ϳ0.06 mmol ⅐ L Ϫ1 ⅐ min Ϫ1 . During the initial 10 min of the full fMRI time course (EU fMRI; Fig. 1 ), the time-weighted average Ϯ SE of blood glucose was 4.97 Ϯ 0.11 mmol/L for T1DM and 4.89 Ϯ 0.15 mmol/L for the control group. During the last 10 min of the full fMRI time course (HY fMRI; Fig. 1 ), the time-weighted average Ϯ SE of blood glucose was 3.36 Ϯ 0.08 mmol/L for T1DM and 3.27 Ϯ 0.12 mmol/L for the control group.
In the first stage of the dual regression, each subject's conditionspecific fMRI dataset (analyses were performed for both the EU and HY condition fMRI runs) was regressed against the full set of group IC maps identified from the full group ICA. This multiple spatial regression resulted in estimates of what are essentially the subject-specific time courses corresponding to each IC map. The full set of ICs was used at this stage, although final estimation of group/condition differences and statistical inference was done only for the seven components of interest. Including the full set of IC maps in the dual regression allowed for artifactual signals to also be modeled in the regression, thus reducing unexplained variance in the multiple regression. The subject-specific time courses from the first stage were used in a second multiple regression of each subjects' fMRI data against the full set of time courses. In this way, each subject's unique spatial pattern of the RSN identified in the group ICA was calculated.
Once all subject-specific spatial maps were calculated, estimation and inference of group/condition differences was done using a standard group general linear model (GLM) approach with nonparametric permutation testing with FSL Randomize (Nichols and Holmes, 2002; . For example, to assess group differences between T1DM and controls during euglycemia, for each of the seven RSNs of interest, the set of subject-specific spatial maps (for the euglycemic condition) were collected into one file, resulting in seven sets of 26 3D spatial maps (one map for each of 16 patients with T1DM and 10 control subjects). Each set of spatial maps was assessed separately for group differences in within-network FC using nonparametric permutation testing with FSL Randomize (Nichols and Holmes, 2002; , with cluster-based thresholding corrected for multiple comparisons by using the null distribution of the maximum cluster size (across the image). The cluster-forming threshold was z ϭ 2.3, and a familywise error corrected threshold of p Ͻ 0.05 was used to define clusters showing significant differences in connectivity (Nichols and Hayasaka, 2003) .
Differences in FC were assessed as follows: (1) between T1DM and control subjects during the euglycemic condition, using an unpaired t test; (2) between T1DM and control subjects during the hypoglycemic condition, using an unpaired t test; (3) between the euglycemic and hypoglycemic conditions for patients with T1DM and controls, separately, using a paired t test; and (4) for differences between patients with T1DM and controls in the changes between hypoglycemia and euglycemia, using an unpaired t test. In addition, HbA1c values and hypoglycemia symptom scores (mean centered within each group) were included as covariates in all models to determine whether or not these values explained any variability of the values around the means. For the models assessing group differences, mean centering within each group was used because HbA1c is used to establish the presence of T1DM, thus the covariates actually contribute to defining the two groups. Specifically, symptom scores during euglycemia were included in model 1, symptom scores measured during hypoglycemia in model 2, and the change in symptom scores (hypoglycemia Ϫ euglycemia) in model 3. Reduced models were run to check for consistency in the estimation of effects (only results obtained with full models are presented as all reduced models were consistent with the full models). Corrections for comparisons across group/condition level tests were not done. This is consistent with current practice in fMRI analyses to do a rigorous multiple comparisons correction for the ϳ50,000 voxelwise tests but not to further correct across the comparatively small number of tests at the group or condition level that are defined a priori in fMRI analyses. For example, conducting multiple hypothesis tests through different contrasts using a GLM is the most common style of analysis of fMRI data (and is what we have done in our analysis), yet these tests are not corrected for multiple contrasts (Perneger, 1998) .
Results

Demographics
Demographic and clinical characteristics of the subjects are presented in Table 1 . As expected, the mean Ϯ SD HbA1c of patients with T1DM was significantly higher than that of nondiabetic controls (7.2 Ϯ 0.9 vs 5.1 Ϯ 0.3%; 55 Ϯ 7 vs 34 Ϯ 2 mmol/mol, p Ͻ 0.001), as was the average fasting plasma glucose level (6.3 Ϯ 1.6 vs 5.1 Ϯ 0.2 mmol/L, p Ͻ 0.05). Average duration of diabetes for the patients was 16 Ϯ 6 years. Historical information on patients' lifetime history of hypoglycemia included frequency of severe hypoglycemic reactions (range of 0 -2 episodes per patient), loss of consciousness (range of 0 -2 episodes per patient), seizures (range of 0 -2 episodes per patient), coma (no episodes in any patient), and emergency room visits as a result of hypoglycemia (range of 0 -8 episodes per patient). One patient with T1DM had reduced hypoglycemia awareness according to the Clarke questionnaire (Clarke et al., 1995). Groups were well matched for age ( p ϭ 0.97), gender ( 2 ϭ 0.88, p ϭ 0.35), fasting insulin ( p ϭ 0.38), and body mass index ( p ϭ 0.78). There were no significant differences between groups in either systolic ( p ϭ 0.50) or diastolic ( p ϭ 0.52) blood pressure assessed during the screening visit.
Insulin clamp
In this study, our goal was to investigate the changes in brain regional FC during the gradual induction of hypoglycemia to closely mimic the physiologic conditions experienced by an individual with T1DM during daily life. The onset of hypoglycemia in T1DM typically develops slowly over 30 -60 min. Plasma glucose levels during the study are shown in Figure 1 . Glucose levels were slightly, but significantly, higher in patients with T1DM versus controls during the basal period and the first 20 min of the euglycemic clamp (basal, 6.26 Ϯ 0.41 vs 5.08 Ϯ 0.07 mmol/L, p Ͻ 0.05). However, by the end of the euglycemic period and during the primary experimental period of declining glycemia, there were no significant differences in glucose levels between groups. Levels of counter-regulatory hormones during the different phases of the study are presented in Figure 2A . Hormone levels did not rise appreciably in either group during the hypoglycemia phase because plasma glucose levels had just reached the typical threshold for a counter-regulatory response only a few minutes earlier. No group or condition difference Regions in network are bilateral unless specified (left or right). T1DM, result in T1DM patient group; CONT, result in nondiabetic control subject group; EU, euglycemia; HY, hypoglycemia; ⌬FC HY-EU , change in FC from euglycemia to hypoglycemia; ⌬Sx HY-EU , change in hypoglycemic symptom score from euglycemia to hypoglycemia.
Hypoglycemic symptom scores
Scores from the questionnaire reporting hypoglycemic symptoms are summarized in Figure 2B . The scores from one patient with T1DM are missing from the analysis because the subject declined to perform the questionnaire. During both euglycemic and hypoglycemic conditions, patients with T1DM reported experiencing significantly stronger symptoms than controls (EU, 4.8 points higher, p Ͻ 0.003; HY, 10.7 points higher, p Ͻ 0.002).
For the T1DM group, the average hypoglycemic symptom score increased significantly during hypoglycemia (change from EU to HY, 6.2 Ϯ 7.6; Fig. 2) ; individual score changes ranged from Ϫ12 to 17, indicating that some patients had reduced symptoms during hypoglycemia, whereas most others had increased symptoms (see Fig. 6 ). Although there was no significant change of average symptom score from euglycemia to hypoglycemia for the control group (change from EU to HY, 0.3 Ϯ 2.6; Fig. 2 ), individual changes ranged from Ϫ4 to 6, thus indicating that some controls had slightly reduced symptoms, most had no symptom change, whereas some others had moderately increased symptoms during hypoglycemia (see Fig. 6 ).
Identification of RSNs from the whole-group ICA
The functional significance of RSNs, which are found consistently across subjects, can be suggested by their spatial similarity with networks that have been shown in other studies to activate during given tasks (Damoiseaux et al., 2006) . From the group ICA, we identified one RSN containing the hypothalamus that was similar to the hypothalamus seed-based network found in our previous report (Musen et al., 2008) and showed other functionally connected regions of ventral brainstem, bilateral caudate, and bilateral posterior insula. We additionally identified six RSNs showing a large overlap with those that have been implicated in feeding behaviors, insulin resistance, obesity, motor planning, and cognition Kullmann et al., 2012) . These RSNs are described in Table 2 with their previously reported functional significance. The spatial maps of the six RSNs that presented significant group or condition differences are shown in Figure 3 . We labeled the RSNs with the letters A through G and gave them names (RSN A-RSN G) according to the main brain regions in the network or reported functional significance: (A) hypothalamus-basal ganglia (caudate); (B) cerebellum-basal ganglia (putamen, pallidum); (C) temporal lobe; (D) DMN; (E) sensorimotor cortex; (F) medial prefrontal lobe or executive control network (ECN); and (G) dorsolateral prefrontal lobe.
Group and condition effects, and correlations of FC changes with symptoms and HbA1c
Results for FC group and condition comparisons are summarized in the last column of Table 2 and in Figure 4 . In patients with T1DM, the left striatum and frontal lobe regions expressed higher FC with the hypothalamus network (RSN A) relative to controls during euglycemia. In controls, right anterior insula and ventral-frontal FC with the basal ganglia and cerebellum decreased (RSN B) and temporal lobe FC decreased (RSN C) during hypoglycemia relative to euglycemia; posterior cingulate and precuneus FC with DMN increased (RSN D) and sensorimotor cortex FC increased (RSN E). In patients with T1DM, right anterior insula and medial frontal FC increased during hypoglycemia relative to euglycemia (RSN F). There were no group or condition differences in the dorsolateral prefrontal lobe network (RSN G; data not shown).
Results for correlations between regional FC changes from euglycemia to hypoglycemia and the HbA1c of patients with T1DM and the changes in symptom scores of nondiabetic controls are summarized in the last column of Table 2 and in Figures  5 and 6 . In patients with T1DM, the right insular cortex and medial frontal FC changes during hypoglycemia with the ECN (RSN F) were correlated positively with HbA1c levels (R 2 ϭ 0.733, p ϭ 0.001). In controls, the FC changes during hypoglycemia of the hypothalamus and basal ganglia with the cerebellumbasal ganglia network (RSN B) were correlated negatively with hypoglycemic symptom score changes (R 2 ϭ 0.831, p ϭ 0.003). A post hoc analysis revealed a stronger correlation of FC changes with neuroglycopenic symptom changes than with autonomic symptom changes (controls: neuroglycopenic, R 2 ϭ 0.749, p ϭ 0.01; autonomic, R 2 ϭ 0.449, p ϭ 0.19). No significant correlations with symptom changes were found for patients with T1DM (neuroglycopenic, R 2 ϭ 0.003, p ϭ 0.99; autonomic, R 2 ϭ 0.007, p ϭ 0.98).
The data were reanalyzed excluding the patient with hypoglycemia unawareness, and there were no statistically significant or clinically meaningful differences in the results.
Discussion
We examined brain RSN FC of patients with T1DM compared with nondiabetic controls during experimentally induced mild hypoglycemia. We found both between-and within-group FC differences in subcortical and cortical brain regions involved in interoception, habitual feeding behavior, and cognition. We also found group-specific correlations between hypoglycemic FC, hypoglycemic symptoms, and HbA1c.
For the hypothalamus-basal ganglia (caudate) network (RSN A), patients with T1DM showed greater FC with left putamen than controls did during euglycemia. Patients also reported higher hypoglycemic symptom scores during euglycemia. The basal ganglia are involved in motor learning, motivation, and control of habitual behavior (Redgrave et al., 2010) . The strength of FC in RSNs is influenced by experience (Albert et al., 2009; Lewis et al., 2009; Fornito and Bullmore, 2010; Corbetta, 2012) . Thus, glycemic experience could have contributed to this connectivity alteration: repeated exposure to high or low glycemic levels could lead to neuroplastic adaptations that may have increased FC in this RSN. Such an adaptive mechanism could underlie a heightened ability to recognize or tendency to report hypoglycemia symptoms.
For the other RSNs, the two subject groups showed different patterns of changes during hypoglycemia. The control group showed decreased FC of the right anterior insula with the cerebellum and basal ganglia (putamen, pallidum) network (RSN B) and with the temporal pole network (RSN C). Furthermore, decreased FC of the right putamen, hypothalamus, and brainstem with RSN B was associated with an increase in hypoglycemic symptoms, more strongly with neuroglycopenic than autonomic ones. This suggests that the regional FC decreases with RSN B play a role in hypoglycemia awareness in controls. These RSNs have been associated with interoceptive, emotional, and autonomic processing; therefore, these changes in FC may provide a mechanism for processing information about glycemic-related physiologic changes. Changes in activation response to visual presentation of high-calorie foods have been observed in some of these regions (e.g., hypothalamus and putamen) during hypoglycemia in nondiabetic individuals, and these changes were associated with increased hunger ratings (Page et al., 2011) . Thus, these FC changes may also play a role in motivation and food-seeking behavior. The right anterior insula supports visceral responses and interoceptive awareness (Craig, 2002; Critchley et al., 2004) .
Therefore, decreased FC of the right anterior insula with RSN B and RSN C during hypoglycemia could also reflect altered signaling of visceral changes contributing to the neuroglycopenic symptoms. Likewise, reduced FC of the right amygdala with RSN C could reflect compromised signaling of danger. The lack of these findings in T1DM suggests that repeated exposures to hypoglycemia may change FC, resulting in altered mediation of awareness or motivational signals.
The control group showed increased FC of the precuneus and posterior cingulate cortex in the DMN (RSN D) and increased FC of the precentral and postcentral cortical regions in the sensorimotor network (RSN E) during hypoglycemia. This is consistent with our previous observation of decreased deactivation in the posterior cingulate cortex during a working memory task in control subjects during hypoglycemia (Bolo et al., 2011) . Increased connectivity of the DMN during hypoglycemia could interfere with task-related deactivations and activations. A study using positron emission tomography (PET) of 15 O-labeled water to measure changes in brain perfusion in hypoglycemic-naive healthy controls during similarly mild early hypoglycemia (2.7 mmol/L; Teh et al., 2010) showed increased perfusion in the anterior cingulate cortex and thalamus, regions of the DMN, as well as in the striatum, ventromedial prefrontal cortex, and insula during later stable hyperglycemia. Our findings in the DMN could be related to the increases found by PET, with differences attributable to the methodological differences between our studies. Notably, Teh et al. (2010) compared euglycemia and early induction of hypoglycemia to later stable hypoglycemia and found more pronounced increases in more regions, whereas our study compared euglycemia and early hypoglycemia during a progressive glycemic descent. It is possible that we might have captured more changes of FC in similar regions if we had compared with resting state fMRI data acquired during a later stable hypoglycemic phase of the clamp. Together, the findings implicate in- creased FC of regions of the DMN during induction of hypoglycemia in healthy hypoglycemic-naive control subjects. Our study suggests that this response is attenuated in T1DM. Alterations of sensorimotor RSN FC were also found in T1DM in a recent resting state fMRI study performed at basal glycemic levels (van Duinkerken et al., 2012) : patients without microangiopathy showed increased (and patients with microangiopathy showed decreased) FC relative to controls. Although experimental conditions and patient groups were different, our findings of an attenuated sensorimotor network response to hypoglycemia in T1DM are compatible with those results and could be explained by similar early shifts or regional reorganizations of RSN FC related to chronic hyperglycemia.
Patients with T1DM showed increased FC during hypoglycemia of the right anterior insula, basal ganglia, and precentral frontal cortex with the medial prefrontal cortex network (RSN F), also known as the ECN, which plays an important role in cognition. This increased prefrontal connectivity is also compatible with our previous finding of increased prefrontal activation during working memory (Bolo et al., 2011) . Increased FC in this cognitive processing-related network may be an adaptation to multiple episodes of hypoglycemia reflecting increased maintenance of cognitive function during hypoglycemic challenges. Similar medial prefrontal cortex regions were found to have increased FC in obese versus lean individuals during visual processing of food stimuli (Kullmann et al., 2013) . Thus, these changes could also be related to food-seeking behavior and to the tendency for individuals with T1DM to gain weight.
Changes in brainstem and right putamen connectivity with the cerebellum-basal ganglia network (RSN B) during hypoglycemia were correlated with changes in self-reported hypoglycemic symptom scores for controls only. This suggests a role for these regions in hypoglycemia awareness, which could modulate motivation for food-seeking behaviors. The correlation was dominated by neuroglycopenic symptoms. For controls, the experience of hypoglycemia is novel. Because the basal ganglia are involved in rule learning and habit control, these connectivity changes may be part of a learning process associating neuroglycopenic perceptions with low blood glucose. Such a transitory learning process could explain the lack of correlation in patients with T1DM who have experienced several hypoglycemic episodes.
Changes in ECN FC in T1DM during hypoglycemia were correlated with HbA1c, suggesting that more frequent exposure to higher glycemic levels and consequently larger excursions during hypoglycemic episodes may have altered regional glucose and neurotransmitter metabolism in this network with a resulting effect on FC. The association of connectivity changes with HbA1c implies an association with previous glycemic control: insula and prefrontal hypoglycemic FC was decreased for patients with HbA1c closer to the normal range (approximately Ͻ7.0%, 53 mmol/mol) and increased for patients with higher HbA1c (approximately Ն7.0%, 53 mmol/mol). Thus, connectivity changes in T1DM with poor glycemic control may reflect a metabolic adaptation to severe chronic hyperglycemia. The FC changes for patients with T1DM with low HbA1c were in the same range as those for nondiabetic controls. Studies using proton magnetic resonance spectroscopy have shown that patients with T1DM maintain brain glutamate levels during moderate hypoglycemia compared with controls who show significant decreases (Bischof et al., 2006; Terpstra et al., 2014) . Thus, the hyperconnectivity of the ECN during hypoglycemia could be attributable to the maintenance of high glutamatergic neurotransmission or glutamate levels driven by increased glucose or energetic metabolism related to persistent hyperglycemia.
Furthermore, we note that the regions of the ECN showing increased connectivity during hypoglycemia are similar to the superior prefrontal cortical regions in which we have also recently reported cortical thickness deficits in T1DM potentially related to glutamate hyperactivity and its excitotoxic effects (Lyoo et al., 2012) and associated with cognitive deficits and depression. Together, our findings suggest that the ECN may also present prefrontal hyperconnectivity during persistent hyperglycemia in T1DM, which may mediate cognitive and emotional dysfunction. We are currently investigating this hypothesis.
Plasma glucose levels were slightly but significantly higher in patients with T1DM versus controls ϳ1 h before the start of the study but were brought to equivalent levels during the euglycemic clamp. It is possible that differences between patients and controls in the rate of glucose washout from brain tissue may have affected our results.
Changes in FC and hypoglycemic symptoms occurred without significant changes in counter-regulatory hormones. During declining glycemia, plasma glucose was only below the level required for activation of a hypoglycemic response (ϳ3.9 mmol/L) for the final 10 -15 min. This suggests that symptomatic responses and changes in connectivity occurred as a result of low plasma glucose levels and were not mediated by an increase in counter-regulatory hormones.
The overall power of the comparisons in our study may be limited because of the relatively small number of participants in each group (n ϭ 10 for controls and n ϭ 16 for T1DM). Also, the unequal number of subjects in each group and the use of unpaired and paired t test, respectively, in the group and condition comparisons results in unequal power between the comparisons. Additional studies with larger groups are needed.
In summary, our study suggests that changes in FC within RSNs that contain core nodes including hypothalamus, basal ganglia, insula, default mode, sensorimotor and cingulate cortices, and cerebellum play an important role in awareness and behavioral response to hypoglycemia. Hypoglycemia induced changes in multiple RSNs in controls and in the ECN in T1DM. The different FC response between groups may stem from familiarity with hypoglycemia in T1DM. Repeated exposure to high and low glycemic levels in T1DM may reinforce FC via neuroplasticity-related mechanisms and shift a multiple network response to a frontal ECN response. This could reflect a cognitive neuroplastic adaptation to chronic hyperglycemic levels, which may normalize with good glycemic control. The frequent exposure to high and low blood glucose levels also likely perturbs brain glucose, energetic, and neurotransmitter metabolic pathways by metabolic adaptive mechanisms (Ö z et al., 2012; Seaquist and Ö z, 2013; van de Ven et al., 2013; Terpstra et al., 2014) , which could underlie broad perturbations of RSN FC patterns. More studies linking brain metabolism and function are needed to understand the mechanisms by which glucose metabolic dysregulation may affect cognition, emotion, and behavior.
